Seminarios
26, Sep 2022
"Revisiting the grammar of Huntingtin aggregation, inclusion formation and toxicity in Huntington’s disease"
Dr. Hilal Lashuel - EPFL, Switzerlan
26, Sep 2022
"Amyloids in signaling processes as seen by solid-state NMR"
Dr. Antoine Loquet - University of Bordeaux, France
19, Sep 2022
"Antimicrobial and Antifungal Saliva Protein Histatin 5"
Dr. Marie Skepö - Lund University, Sweden
19, Sep 2022
" Chaperoning protein aggregation diseases"
Dr. Stefan Rüdiger Utrecht University, Netherlands
12, Sep 2022
"The polymorphic landscape of amyloid assembly revealed by AFM and individual particle structural reconstruction"
Dr. Wei-Feng Xue - University of Kent,UK
12, Sep 2022
"Amyloid polymorphism in neurodegenerative disease"
Dr. Per Hammarström - Linköping University, Sweden
02, May 2022
"Kinetics-Based Drug Discovery for Neurodegenerative Diseases"
Dr. Michele Vendruscolo - University of Cambridge, UK
02, May 2022
"Strains of Pathological Protein Aggregates in Neurodegenerative Diseases"
Dr. Joel Watts - University of Toronto, Canada
21, Feb 2022
“Toward early Diagnosis and Therapy of Alzheimer´s Disease”
Dr. Shai Rahimipour - Bar – IIan University, Israel
21, Feb 2022
“Thermodynamics of amyloid fibril formation”n”
Dr. Alexander Kai Büll Technical University of Denmark
14, Feb 2022
“Natural amyloid fibrils as catalysts of physiological and pathological reactions: a new paradigm in disease?”
Dr. Raz Jelinek Ben–Gurion University, Israel
14, Feb 2022
“Molecular Aspects of protein Aggregation”
Dr. Claudio Luchinat CERM, Florence, Italy
23, Sep 2021
Stabilization of α-synuclein oligomers using formaldehyde
Dr. Phelippe Do carmo Goncalves, Prof. Jésica Soledad Flores
09, Sep 2021
Inhibition of alpha-synuclein seeded fibril formation and toxicity by herbal medicinal extracts.
Dr. Francisco Hita
06, Jul 2021
Bacillus subtilis como organismo modelo para el estudio del rol de la microbiota en la prevención del aging y enfermedades neurodegenerativas
Dr. Roberto Grau
07, Jun 2021
"The small molecule inhibitor anle145c thermodynamically traps human islet amyloid peptide in the form of non-cytotoxic oligomers"
Dra. Carolina Arrúa
11, May 2021
Ciclo de Seminarios del MPLbioR
Ver más
27, Abr 2021
Neurobiología molecular y celular, polarización neuronal, estructura de citoesqueleto, dendritas y axones, redes y circuitos. Transporte axonal y enfermedades neurodegenerativas.
Ver más
25, Abr 2021
Lectura y discusión de Papers
Ver más
23, Abr 2021
Modificaciones celulares por el tratamiento en Enfermedad de Parkinson
Ver más
09, Abr 2021
Neuronas dopaminérgicas MARCAPASO cerebral
Ver más
15, Oct 2020
"Prasinezumab Slows Progression On Measures Of Parkinson’s Disease In Phase 2 Study"
Ver más
08, Oct 2020
"Modeling Parkinson´s Disease in C. elegans"
Nicola Boeffinger
Ver más
01, Oct 2020
"Trans-synaptic and retrograde axonal spread of Lewy pathology following pre-formed fibril injection in an in vivo A53T alpha-synuclein mouse model of synucleinopathy"
Dr. Tomas de la Riestra
Ver más
24, Sep 2020
"LABSO-Bio y MPLbioR: 8 años de fructífera colaboración científica"
Dr. Nicolás A. Rey
Ver más
17, Sep 2020
"A Master Regulator of α‑Synuclein Aggregation"
Dr. Phelippe Gonçalves
Ver más
10, Sep 2020
"Discriminating α-synuclein strains in Parkinson’s disease and multiple system atrophy"
Dr. Francisco J. Hita
Ver más
03, Sep 2020
"Anti-amyloid compounds inhibit α-Synuclein aggregation induced by Protein Misfolding Cyclic Amplification (PMCA)"
Dr. Francisco J. Hita
Ver más